Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhonghua Gan Zang Bing Za Zhi ; 32(3): 257-261, 2024 Mar 20.
Artigo em Chinês | MEDLINE | ID: mdl-38584111

RESUMO

Systemic treatment, including molecular targeted therapy, immunotherapy, and chemotherapy, is an important means of achieving long-term survival in patients with intermediate-and advanced-stage liver cancer. However, some patients are insensitive to treatment and even develop drug resistance. Mitochondria are the center of cellular energy metabolism and, at the same time, are the priority targets for systemic therapy. Mitochondrial homeostasis plays an important role in the treatment of liver cancer. The relationship between the two advances is elucidated so as to provide better ideas for the clinical treatment of liver cancer.


Assuntos
Neoplasias Hepáticas , Mitocôndrias , Humanos , Imunoterapia , Neoplasias Hepáticas/terapia , Neoplasias Hepáticas/metabolismo , Homeostase
2.
Zhonghua Gan Zang Bing Za Zhi ; 31(10): 1108-1112, 2023 Oct 20.
Artigo em Chinês | MEDLINE | ID: mdl-38016782

RESUMO

Molecular targeted drugs are one of the treatments for hepatocellular carcinoma (HCC), the primary factor influencing their therapeutic efficacy is drug resistance. Diminished drug intake, greater efflux, improved DNA damage repair capacity, aberrant signal pathways, hypoxia, epithelial-mesenchymal cell transition, and the cellular autophagy system are summarized herein as aspects of the drug resistance mechanism. Simultaneously, effective strategies for addressing drug resistance are elaborated, providing ideas for better clinical treatment of HCC.


Assuntos
Carcinoma Hepatocelular , Neoplasias Hepáticas , Humanos , Neoplasias Hepáticas/patologia , Carcinoma Hepatocelular/patologia , Terapia de Alvo Molecular , Transdução de Sinais , Resistência a Medicamentos , Resistencia a Medicamentos Antineoplásicos , Linhagem Celular Tumoral , Transição Epitelial-Mesenquimal/fisiologia
3.
Lett Appl Microbiol ; 69(2): 100-109, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31107978

RESUMO

Members of the genus Aeromonas are opportunistic pathogen of a variety of aquatic animals that exhibits multidrug resistance, phenotypes, virulence genes and virulence. The present study described the species distribution and the potential pathogenicity of Aeromonas isolated from healthy Northern snakehead (Channa argus) in China. Molecular identification revealed that A. veronii biovar veronii (69/167; 41·3%) and A. hydrophila (41/167; 24·6%) were the most common species found in Northern snakehead intestine based on sequencing of the 16S rRNA gene and DNA gyrase subunit B protein. The distribution of seven virulence factors including aer (84·4%), act (80·8%), ser (40·1%), Aha (27·5%), lip (23·4%), exu (15·0%) and LuxS (12·6%) were determined exclusively in Aeromonas isolates. All the seven virulence genes were present in 9·6% (16/167), among which 11 strains were identified as A. veronii biovar veronii. For the strains harbouring seven virulence genes, the 50% lethal doses (LD50 ) of isolates were lower compared to the isolates carrying two virulence genes. The challenge tests revealed that isolate W31 had the lowest lethal dose, causing 50% mortality at 4·5 × 103 colony-forming units (CFU) per ml. Furthermore, histopathology of Northern snakehead infected with Aeromonas strains showed necrosis and congestion in liver, spleen and kidney and also damage to the intestine. This study confirms that the Aeromonas strains isolated from healthy Northern snakehead may be a cause of concern for public health. SIGNIFICANCE AND IMPACT OF THE STUDY: Aeromonas species are widely distributed in aquatic environments and have considerable virulence potential. The aim of this study was to identify Aeromonas strains isolated from healthy Northern snakehead, and to investigate if Aeromonas species isolated from healthy fish potential pathogenicity with special reference to virulence and epidemiology studies.


Assuntos
Aeromonas/patogenicidade , Doenças dos Peixes/microbiologia , Infecções por Bactérias Gram-Negativas/veterinária , Fatores de Virulência/genética , Aeromonas/genética , Aeromonas/isolamento & purificação , Animais , Proteínas de Bactérias/genética , China/epidemiologia , DNA Girase/genética , Doenças dos Peixes/epidemiologia , Doenças dos Peixes/patologia , Peixes , Infecções por Bactérias Gram-Negativas/epidemiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Infecções por Bactérias Gram-Negativas/patologia , Humanos , Saúde Pública , Virulência/genética
4.
Sleep Breath ; 21(1): 191-195, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28101753

RESUMO

PURPOSE: Primary insomnia is a persistent and recurrent disorder as well as a risk factor for depression. The aim of this study was to determine whether the zolpidem combined with paroxetine would be effective in the treatment of patients with primary insomnia. METHODS: Ninety patients meeting DSM-IV criteria for primary insomnia were randomly assigned to 8 weeks of treatment with zolpidem combined with paroxetine (the combined treatment group, n = 45) or zolpidem combined with placebo (the control group, n = 45). Patients were assessed with the Pittsburgh Sleep Quality Index (PSQI), polysomnography (PSG), and the Treatment Emergent Symptom Scale (TESS). RESULTS: Compared with the control group, the combined treatment group was more significantly improved on wake time after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), and total PSQI scores, but not the sleep onset latency (SOL). CONCLUSIONS: Eight weeks of the zolpidem combined with paroxetine treatment to patients with primary insomnia is more effective than zolpidem treatment only in sleep maintenance and early morning awakenings.


Assuntos
Paroxetina/efeitos adversos , Paroxetina/uso terapêutico , Piridinas/efeitos adversos , Piridinas/uso terapêutico , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Adulto , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polissonografia , Resultado do Tratamento , Vigília/efeitos dos fármacos , Zolpidem
6.
Zhonghua Wai Ke Za Zhi ; 28(6): 342-5, 381, 1990 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-2096058

RESUMO

From 1984 to 1986, 56 cases with traumatic paraplegia were treated by transplanting the intact omentum to the injured spinal cord. All patients were followed up 1 to 4 years. In these patients, the sensory level descended variously in 80.0%, muscular power increased in different degrees in 60.9% and sphincter function improved in 76.8%. The indications of this operation are incomplete paraplegia with EMG showing nervous activity. Satisfactory effects can be expected in injuries of the thoracolumbar segments and in mild contusion spinal cord. Fistula with of leak of cerebrospinal fluid, is a severe complication, it may be prevented by suturing the omentum to the dura, complete hemostasis, and tight muscular suturing. The absorb function of the omentum also helps in its prevention.


Assuntos
Omento/transplante , Medula Espinal/cirurgia , Traumatismos da Coluna Vertebral/cirurgia , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Paraplegia/cirurgia , Complicações Pós-Operatórias/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...